AMR101 – Omega-3-Based Treatment for Hypertriglyceridaemia, United Kingdom
Under development by Amarin Corporation, AMR101 is a partially synthetic omega-3 fatty acid-based drug. It contains the purest form of the active ingredient, ethyl...
Navidea signs China commercialization deal for Lymphoseek
Navidea Biopharmaceuticals Inc. has licensed its radioactive cancer diagnostic aid Lymphoseek to a Chinese pharmaceutical company that will have exclusive rights bring the drug...
Navidea signs China commercialization deal for Lymphoseek
Navidea Biopharmaceuticals Inc. has licensed its radioactive cancer diagnostic aid Lymphoseek to a Chinese pharmaceutical company that will have exclusive rights bring the drug...
ViiV Healthcare’s Triumeq for HIV treatment receives EU marketing authorisation
GlaxoSmithKline's ViiV Healthcare has received marketing authorisation from the European Commission (EC) for its Triumeq (dolutegravir 50mg/abacavir 600mg/lamivudine 300mg) tablets to treat HIV in...
UCC RESEARCH TO HELP MALARIA VACCINE DEVELOPMENT
Researchers at UCC have developed a microneedle-based patch that results in increased vaccine-induced protection against malaria infection using lower doses of vaccine in...
Liverpool-based Redx Pharma secures ‘transformational’ deal with drugs giant AstraZeneca
Liverpool biotech firm Redx Pharma has signed a “transformational” multi-million pound deal with global pharmaceutical giant AstraZeneca to develop new drugs that will stop...
Novartis’ new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark PARADIGM-HF trial
Today at the European Society of Cardiology congress and published simultaneously in the New England Journal of Medicine, Novartis revealed that its investigational heart...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...